Genomic Profile Comparison
Genomic Profile Comparison - Related Videos
02:54
Evolutionary Relationships through Genome Comparisons
0 Views •
2021
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
01:14
Drug Dissolution: Requirements and Profile Comparison
0 Views •
2025
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
08:31
Isolation and Genome Analysis of Single Virions using 'Single Virus Genomics'
0 Views •
Cited by 2 •
2013
Single Virus Genomics (SVG) is a method to isolate and amplify the genomes of single virons. Viral suspensions of a mixed assemblage are sorted using flow cytometry onto a microscope slide with discrete wells containing agarose, thereby capturing the virion and reducing genome shearing during downstream processing. Whole genome amplification is achieved using multiple displacement amplification (MDA) resulting in genomic material that is suitable for sequencing.
10:16
Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
0 Views •
Cited by 115 •
2018
DNA regulatory elements, such as enhancers, control gene expression by physically contacting target gene promoters, often through long-range chromosomal interactions spanning large genomic distances. Promoter Capture Hi-C (PCHi-C) identifies significant interactions between promoters and distal regions, enabling the assignment of potential regulatory sequences to their target genes.
12:57
Genome-wide Quantification of Translation in Budding Yeast by Ribosome Profiling
0 Views •
Cited by 7 •
2017
Translational regulation plays an important role in the control of protein abundance. Here, we describe a high-throughput method for quantitative analysis of translation in the budding yeast Saccharomyces cerevisiae.
FAQs
Comparison depends on placing genomic data into a common analytical framework before differences are interpreted. Investigators align sequencing-derived profiles, then examine whether samples share or differ in mutations, copy-number alterations, or gene activity patterns. This separates recurring molecular features from sample-specific changes, allowing cancer researchers to relate the resulting patterns to tumor subtype or other biological and clinical outcomes.
Mutations, copy-number alterations, and gene activity patterns provide complementary views of a cancer sample. A mutation identifies a sequence-level difference, whereas a copy-number alteration reflects a change in the amount of a genomic region; gene activity patterns describe differences in expressed activity. Considering these feature types together gives comparisons more biological context than relying on one category alone.
Comparing profiles across tumor samples or stages can expose patterns consistent with clonal evolution, in which related tumor cell populations acquire different genomic features over time. The analysis can also show molecular differences associated with disease progression or treatment response. These comparisons help investigators connect changing genomic patterns with how a cancer develops and how it behaves clinically.
The comparison unit shapes the question being asked. Analyses across cells or tumor samples can emphasize variation within a cancer, while comparisons across tissues or individuals can highlight broader differences between biological or patient groups. Choosing the relevant level helps investigators interpret whether a genomic pattern reflects a shared cancer characteristic, a sample-specific feature, or an individual difference.
A typical analysis begins with sequencing-derived genomic profiles from selected cells, tissues, individuals, or tumor samples. Investigators align the data so corresponding genomic features can be compared, detect variants, and evaluate mutations, copy-number alterations, or gene activity patterns. They then assess whether these differences correspond with tumor subtype, disease progression, treatment response, or other outcomes.
Cancer researchers use this approach when molecular differences may explain why tumors belong to different subtypes, progress differently, or respond differently to treatment. Comparing profiles can reveal patterns associated with clinical or biological outcomes, making the method useful for studying disease progression and for identifying genomic features that distinguish patient or tumor groups.
By linking recurring genomic differences with clinical or biological outcomes, investigators can identify candidate biomarkers, meaning measurable features associated with a relevant cancer characteristic or response. The same comparisons can separate patients or tumor samples into molecularly meaningful groups. These groups support patient stratification and can inform the development of more precise cancer diagnostics and therapies.
The analysis can provide molecular distinctions among tumor subtypes, evidence of genomic changes associated with progression, and patterns related to treatment response. It may also clarify how tumor profiles differ across samples or individuals. Together, these outcomes help connect genomic variation with cancer behavior and provide a foundation for biomarker discovery, diagnostic development, and therapeutic precision.